Compare Elastic NV (ESTC) vs Upwork Inc (UPWK) Price & Performance

Elastic (ESTC) trades at $97.54, up 4.77% on the day, reflecting strong momentum as it approaches resistance near $98. The stock exhibits a bullish technical setup with moving averages supporting the uptrend, though the short-term RSI indicates potential overbought conditions. Fundamentally, the company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, projected to rise from $1.48 billion in 2025 to $1.8 billion in 2026, while net income is expected to swing from a loss to a $376 million profit, signaling improving profitability. Recent news highlights product innovations in AI and observability platforms, reinforcing its competitive edge.

The outlook for ESTC is positive, driven by earnings beats, solid revenue expansion, and strategic product launches in high-growth areas like AI and data search. Key risks include high valuation multiples, such as a P/E of 27.22 and EV/EBITDA of 496.59, which may limit upside if growth slows. Analyst consensus is strongly bullish with a 64.71% buy rating, though the average price target of $79.50 suggests caution relative to the current price. Investors should weigh the strong fundamental trajectory against valuation concerns and market volatility.

Upwork (UPWK) trades at $8.60, up 2.38% today, with a bearish technical signal despite recent earnings beat. The stock shows strong fundamentals with 77.21% gross margins and 12.93% net income margin, though revenue growth has stalled at $788M in 2025. Recent insider selling and ongoing securities fraud investigations create headwinds, while institutional buying from Bank of America provides some support. Technical indicators show resistance at $9 and support at $8.

The stock presents a mixed outlook with attractive valuation metrics (P/E 10.99, P/S 1.48) but faces significant AI disruption risks and declining active clients. Analyst consensus leans bullish with $9.64 price target, though near-term challenges from weak guidance and legal scrutiny may limit upside potential.